ArticleFrontiers in pharmacology2026

Targeted nanoparticle-mediated Co-delivery of IFITM3 KO and ponatinib reverses TKI resistance in chronic myeloid leukemia.

Zhenyang Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.